Imcivree Medication
Imcivree medication is one of the available medications in the treatment of obesity and management of hunger from the genetic conditions of the brain. Imcivree also controls weight by altering the metabolism of the body. Hunger is directly associated with the intake of excess calories, which increases body weight. The medication can be used in children over six years and adults with genetic factors associated with obesity. The use of the medication relies on the understanding of the specific concepts and how the medication works. The paper seeks to explore the effectiveness of Imcivree in reducing body weight and determining the effectiveness of the medication on feelings of hunger.
Recommendations
The abstract is the most important page in the document as it is the window into the quality of a study. An abstract cannot exceed 1 page and must be on it’s own page. It is not indented. See section 2.9 p. 38 of the APA, 7th edition manual.
not worded well. Avoid anthropomorphisms. See APA page 117, section 4.11 to learn more. Anthropomorphism is defined as giving human characteristics to inanimate objects.
• Incorrect: The research study will investigate: note studies should not have human qualities
References
Abbasi, J. (2021). Semaglutide’s Success Could Usher in a “New Dawn” for Obesity Treatment. JAMA, 326(2), 121-123.
Age, F. A., & Contraindications, I. FDA-Approved Drugs to Treat Overweight and Obesity.
Mahmood, I., & Pettinato, M. (2021). Impact of Intrinsic and Extrinsic Factors on the Pharmacokinetics of Peptides: When Is the Assessment of Certain Factors Warranted?. Antibodies, 11(1), 1.
Markham, A. (2021). Setmelanotide: first approval. Drugs, 81(3), 397-403.
POLICY, C. Imcivree (setmelanotide).
